UAE, 7 April 2018 -The Ministry of Health and Prevention has issued public warnings on the use of dietary supplements due to their alarming side effects including sharp drop in blood pressure, anxiety, irritability, nervousness, rapid heartbeat. The ministry also warned against the interaction between some contraceptive medicines and an anti-epileptic. Recently, the Ministry recalled various products for violations and failing to meet the set safety standards, to name a fewfood supplements which contain salmonella bacteria; drug used to relieve heartburn and acid indigestion, and medical device used as a device managing medical image because of the loss of some images.
H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Ministry’s Public Health Policy and Licensing Sector, emphasized that it is part of the Ministry’s mandate to protect community health by issuing circulars warning people against the use of fake food supplements and recalling products, including substandard medical devices, from the market due to their dangerous side effects. In line with its objective to protect community health, the Ministry coordinates with the local health authoritiesto monitor the necessary recall all health facilities.
Issuing warnings is also aligned with the Ministry's strategies to build a quality and safe health system according to international standards and formulate key legislative frameworks and vital governance to regulate the healthcare services. Additionally, the Ministry is also directing all concerned entities to take the necessary procedures to recall the mentioned products to prevent their distribution and importation, though these products are not registered with the drug department in the ministry of health and prevention. In case of side effects resulting from the anymedical drugs or devices, an individual may call the Ministry at 04-3201448, or fax at 02-3201947, or e-mail at pv@ moh.gov.ae
Weight loss products cause low blood pressure and psychological symptoms
H.E. Dr. Al Amiri said that the Ministry’s laboratory for Quality Control and Research of Medical and Health Products has found that the Shedfat Maxx capsule, a weight loss product, produced by Shedfat LLC contains yohimbine. The chemical substance, which is banned worldwide, causes dangerous drop in blood pressure, psychological symptoms such as anxiety, irritability, nervousness, and rapid heartbeat. He asked concerned entities to recall the product, if available, and mentioned that this medicine is not registered with the Department,
Contraceptive drugs causing epileptic seizures
On contraceptive drugs, H.E. Al Amiri said: “Sanofi, has informed us about the update of the label of Depakine, an anti-epileptic medicine containing sodium valproate and valproic acid forms that can interact with estrogen-containing contraceptives. Depakine, which contains valproate, does not affect the effectiveness of estrogen-containing products, however estrogen containing products can accelerate the elimination of valproate form the bodymight lead to a decreased effect.”
“Therefore, health care professionals should monitor their patients if they start or stop using estrogen-containing products and monitor any mood change or seizure. They should also monitor the level of valproate in the blood of these patients,” H.E. added.
Depakine is registered with the Ministry’s Drug Department but health care practitioners are directed to take caution when prescribing the medicine to their patients. It is safe to use and has not been recalled from the market. These warnings are added to the drug labels only. To report its side effects, the public is encouraged to fill out a form available on the Ministry's website; or call 02-3201448; or fax 02-3201947, or e-mail pv@ moh.gov.ae
Food supplements with salmonella recalled
The US Food and Drug Administration (FDA) has recalled Kratom products sold on websites krakenkratom.com, ciosa.comsoulspem, and phytoextractum.com. These products containing kartom herb, scientific name Mitragynaspeciosa, are sold as a food supplement online in the form of capsules, tea, and coffee.
According to the US FDA, these products may contain salmonella bacteria, which may cause poisoning and other symptoms such as fever, diarrhea, nausea, and abdominal pain. The elderly and people with weak immunity are more susceptible to the effects of the bacteria.
With its stimulant effects, kartom has similar characteristics as opium. As per the US FDA, there is no evidence proving that kartom is safe or effective in treating any disease. Some people have taken the product to treat chronic pain, and to treat the symptoms of opium recall and recently has been used for recreational purposes.
The recalled products, according to the US FDA, are produced by the following companies: PDX Aromatics; DBA Kraken Kratom; Phytoextractum; and Soul Speciosa. An action should be taken to recall these products from the market and prevent their circulation and import, the Ministry said. The products are not registered with the Drug Department.
One batch of Food supplements for heartburn or acid indigestion
The Saudi Drug and Food Administration has recalled onebatch of Omacid Chewable tablets produced by Oman Industries Co. National Pharmaceutical. The medicine is used to relieve heartburn and acid indigestion but it has not passed the Assay test. The product is registered in the GCC Centrally. The manufacturer said the product is not available in the UAE. To protect public safety and patient health, the Department has nonetheless taken precautionary measures in case it has entered the local market.
Medical device recalled due to loss of some radiological images
General Electric (GE) has issued a warning about the use of its ‘Centricity Universal Viewer,’ a medical device for medical image management, because of the loss of some radiological images after the tests. The company stated that some hospitals in the country are already using the device. The company will communicate with its suppliers to provide a free of charge system update to fix the issue. This product is not registered with the Ministry’s Drug Department.